NASDAQ:SGNT - Sagent Pharmaceuticals Stock Price, Forecast & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Sagent Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume607,514 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Sagent Pharmaceuticals, Inc is a specialty and generic pharmaceutical company. The Company is a provider of pharmaceuticals to the hospital market, which it sells primarily throughout North America. It is focused on developing, manufacturing, sourcing and marketing injectable pharmaceutical products to the hospital market. It operates through two segments: Sagent US, consisting of the Company's operations in the United States and the Sagent (China) Pharmaceuticals Co Ltd. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryPharmaceuticals SectorN/A Current SymbolNASDAQ:SGNT Previous Symbol CUSIP78669210 CIK1369786 Webhttp://www.sagentpharma.com/ Phone+1-847-9081604Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Receive SGNT News and Ratings via Email Sign-up to receive the latest news and ratings for SGNT and its competitors with MarketBeat's FREE daily newsletter. Sagent Pharmaceuticals (NASDAQ:SGNT) Frequently Asked Questions What is Sagent Pharmaceuticals' stock symbol? Sagent Pharmaceuticals trades on the NASDAQ under the ticker symbol "SGNT." How were Sagent Pharmaceuticals' earnings last quarter? Sagent Pharmaceuticals Inc (NASDAQ:SGNT) announced its earnings results on Tuesday, August, 4th. The company reported ($0.01) EPS for the quarter, missing analysts' consensus estimates of $0.05 by $0.06. The company earned $77.30 million during the quarter, compared to the consensus estimate of $83.28 million. Sagent Pharmaceuticals's revenue for the quarter was up 11.7% compared to the same quarter last year. During the same period last year, the business earned $0.09 EPS. View Sagent Pharmaceuticals' Earnings History. Has Sagent Pharmaceuticals been receiving favorable news coverage? Press coverage about SGNT stock has trended negative recently, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Sagent Pharmaceuticals earned a daily sentiment score of -2.0 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Sagent Pharmaceuticals. Who are some of Sagent Pharmaceuticals' key competitors? Some companies that are related to Sagent Pharmaceuticals include Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Pfizer (PFE), AbbVie (ABBV), Eli Lilly And Co (LLY), Bristol-Myers Squibb (BMY), Allergan (AGN), Zoetis (ZTS), Mylan (MYL), Jazz Pharmaceuticals (JAZZ), Perrigo (PRGO), The Medicines (MDCO), Horizon Therapeutics (HZNP), Nektar Therapeutics (NKTR) and Zogenix (ZGNX). What other stocks do shareholders of Sagent Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sagent Pharmaceuticals investors own include Mazor Robotics (MZOR), NovaBay Pharmaceuticals (NBY), Endocyte (ECYT), Inovio Pharmaceuticals (INO), Surgery Partners (SGRY), SLS International (SLS), Allena Pharmaceuticals (ALNA), Catalyst Biosciences (CBIO), CTI BioPharma (CTIC) and Dare Bioscience (DARE). What is Sagent Pharmaceuticals' official website? The official website for Sagent Pharmaceuticals is http://www.sagentpharma.com/. How can I contact Sagent Pharmaceuticals? Sagent Pharmaceuticals' mailing address is 1901 N Roselle Rd Ste 700, SCHAUMBURG, IL 60195-3194, United States. The company can be reached via phone at +1-847-9081604. MarketBeat Community Rating for Sagent Pharmaceuticals (NASDAQ SGNT)Community Ranking: 2.2 out of 5 ( )Outperform Votes: 189 (Vote Outperform)Underperform Votes: 247 (Vote Underperform)Total Votes: 436MarketBeat's community ratings are surveys of what our community members think about Sagent Pharmaceuticals and other stocks. Vote "Outperform" if you believe SGNT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SGNT will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/10/2019 by MarketBeat.com StaffFeatured Article: What is the Fibonacci sequence?
